| Title | Author(s) | Year | View Count |
 | Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD | Chim, JCS; Lie, AKW; Chan, YET; Liu, HSY; Lau, CW; Yip, SY; Sim, J; Wan, TSK; Ma, ESK; Liang, RHS; Tse, EWC; Kwong, YL | 2012 | 72 |
 | Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia | Tse, E; Leung, AYH; Sim, J; Lee, HKK; Liu, HSY; Yip, SF; Kwong, YL | 2011 | 121 |
|
